BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3789250)

  • 1. Histopathologic features predicting recurrence of meningiomas following subtotal resection.
    de la Monte SM; Flickinger J; Linggood RM
    Am J Surg Pathol; 1986 Dec; 10(12):836-43. PubMed ID: 3789250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
    Abramovich CM; Prayson RA
    Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningioma grading: an analysis of histologic parameters.
    Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
    Am J Surg Pathol; 1997 Dec; 21(12):1455-65. PubMed ID: 9414189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection.
    Barrett OC; Hackney JR; McDonald AM; Willey CD; Bredel M; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):453-459. PubMed ID: 30253235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence and regrowth of benign meningiomas.
    Nakasu S; Fukami T; Jito J; Nozaki K
    Brain Tumor Pathol; 2009; 26(2):69-72. PubMed ID: 19856217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence.
    Ros-Sanjuan A; Iglesias-Moroño S; Carrasco-Brenes A; Bautista-Ojeda D; Arraez-Sanchez MA
    World Neurosurg; 2019 May; 125():e248-e256. PubMed ID: 30684705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features predicting recurrence of intracranial meningiomas.
    Montriwiwatchai P; Kasantikul V; Taecholarn C
    J Med Assoc Thai; 1997 Jul; 80(7):473-8. PubMed ID: 9277078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [X-ray computed tomographic aspects of malignant meningioma and meningeal hemangiopericytoma].
    Dufresne MC; Bédard F
    Can Assoc Radiol J; 1996 Aug; 47(4):279-87. PubMed ID: 8696997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting recurrence of intracranial meningiomas. A multivariate clinicopathologic model--interim report of the New York University Medical Center Meningioma Project.
    Miller DC
    Neurosurg Clin N Am; 1994 Apr; 5(2):193-200. PubMed ID: 8032222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.
    Fukushima Y; Oya S; Nakatomi H; Shibahara J; Hanakita S; Tanaka S; Shin M; Kawai K; Fukayama M; Saito N
    J Neurosurg; 2013 Dec; 119(6):1373-9. PubMed ID: 24053497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term surgical outcomes of spinal meningiomas.
    Nakamura M; Tsuji O; Fujiyoshi K; Hosogane N; Watanabe K; Tsuji T; Ishii K; Toyama Y; Chiba K; Matsumoto M
    Spine (Phila Pa 1976); 2012 May; 37(10):E617-23. PubMed ID: 22146282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
    Perry A; Scheithauer BW; Stafford SL; Lohse CM; Wollan PC
    Cancer; 1999 May; 85(9):2046-56. PubMed ID: 10223247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome.
    Abramovich CM; Prayson RA
    Am J Clin Pathol; 2000 Jul; 114(1):84-92. PubMed ID: 10884803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.
    Schiffer D; Ghimenti C; Fiano V
    J Neurooncol; 2005 Jun; 73(2):125-30. PubMed ID: 15981101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas.
    El-Khatib M; El Majdoub F; Hoevels M; Kocher M; Müller RP; Steiger HJ; Sturm V; Maarouf M
    Acta Neurochir (Wien); 2011 Sep; 153(9):1761-7. PubMed ID: 21706274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing meningioma recurrence rate.
    Naumann M; Meixensberger J
    Acta Neurochir (Wien); 1990; 107(3-4):108-11. PubMed ID: 2077846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurring intracranial meningiomas. Evaluation of some factors predisposing for tumor recurrence.
    Böker DK; Meurer H; Gullotta F
    J Neurosurg Sci; 1985; 29(1):11-7. PubMed ID: 4067631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.